Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|February 22, 2024
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older AdultsChristine A Shaw, Brandon Essink, Charles Harper, et al.
Respiratory Investigation|September 10, 2024
Safety and immunogenicity of an mRNA-based RSV vaccine in Japanese older adults aged ≥60 years: A phase 1, randomized, observer-blind, placebo-controlled trialDavid Fitz-Patrick, Hanako Mihara, Anthony Mills, et al.
The Journal of Infectious Diseases|May 7, 2021
Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in HumansKatherine E Burgomaster, Bryant M Foreman, Maya A Aleshnick, et al.
Plos One|September 19, 2019
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trialCristina Carter, Katherine V Houser, Galina V Yamshchikov, et al.
Cell Reports|May 8, 2024
Immune memory shapes human polyclonal antibody responses to H2N2 vaccinationYuhe R Yang, Julianna Han, Hailee R Perrett, et al.
Biorxiv : the Preprint Server for Biology|October 2, 2023
Immune memory shapes human polyclonal antibody responses to H2N2 vaccinationYuhe R Yang, Julianna Han, Hailee R Perrett, et al.
Immunity|July 28, 2019
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza HemagglutininSarah F Andrews, Michael J Chambers, Chaim A Schramm, et al.
Nature Medicine|February 4, 2022
A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccinationSarah F Andrews, Julie E Raab, Jason Gorman, et al.
The Lancet. Infectious Diseases|May 14, 2022
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trialEmily E Coates, Srilatha Edupuganti, Grace L Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2017
Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of VaccinesLindsay Kim, Brian Rha, Jon S Abramson, et al.
Pageof 5